Recent News

• 09.10.2025 - The Morgan Stanley Annual Global Healthcare Conference
• 09.04.2025 - Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology
• 09.04.2025 - Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology
• 09.04.2025 - How Genomic Testing is Transforming Treatment Decisions in Intermediate-Risk Prostate Cancer
• 09.04.2025 - 50 Years After the Monoclonal Antibody Breakthrough: Why Precision Medicine Still Needs Reinventing
• 09.04.2025 - Facing Fear, Finding Strength: Jodi’s Story of Genetic Testing and Prevention
• 09.03.2025 - New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression
• 09.03.2025 - New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression
• 09.03.2025 - The Wells Fargo Healthcare Conference
• 08.27.2025 - Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

Recent Filings

• 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.19.2025 - 3 Initial statement of beneficial ownership of securities
• 08.18.2025 - 8-K Current report
• 08.18.2025 - EX-99.1 EX-99.1
• 08.18.2025 - 4 Statement of changes in beneficial ownership of securities